ReviewDiseases (Basel, Switzerland)2026
Antihypertensive Drugs as Potential Repositioning Options for Melanoma: A Map of Pre-Clinical Evidence.
Naomi Gerzvolf Mieres, Kauanna Oliveira, Nathália Carolina Barreiro Marques, Nicole Milagritos Cardoso Azorza, Helena Hiemisch Lobo Borba, Roberto Pontarolo, Marcel Henrique Marcondes Sari, Juliana Sartori Bonini, Jéssica Brandão Reolon, Raul Edison Luna Lazo and 1 more
Abstract readReview
In one paragraphReview in Diseases (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Naomi Gerzvolf MieresPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.ORCID 0009-0009-6426-6186 Kauanna OliveiraPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.
Nathália Carolina Barreiro MarquesPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.ORCID 0000-0002-7576-406X Nicole Milagritos Cardoso AzorzaCarrera de Farmacia y Bioquímica, Facultad de Ciencias de la Salud, Universidad Científica del Sur, Villa El Salvador, Lima 15023, Peru.ORCID 0000-0002-3327-2884 Helena Hiemisch Lobo BorbaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.ORCID 0000-0001-9723-584X Roberto PontaroloPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.ORCID 0000-0002-7049-4363 Marcel Henrique Marcondes SariPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.ORCID 0000-0002-9913-9306 Juliana Sartori BoniniPrograma de Pós-Graduação em Ciências Farmacêuticas, Departamento de Farmácia, Universidade Estadual do Centro-Oeste, Guarapuava 85040-167, PR, Brazil.
Jéssica Brandão ReolonPrograma de Pós-Graduação em Ciências Farmacêuticas, Departamento de Farmácia, Universidade Estadual do Centro-Oeste, Guarapuava 85040-167, PR, Brazil.ORCID 0000-0001-7388-8256 Raul Edison Luna LazoCarrera de Farmacia y Bioquímica, Facultad de Ciencias de la Salud, Universidad Científica del Sur, Villa El Salvador, Lima 15023, Peru.ORCID 0000-0002-3434-1239 Luana Mota FerreiraPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal do Paraná, Curitiba 80210-170, PR, Brazil.ORCID 0000-0001-9951-587X Funding
Fundação Araucária #Nº029/2026 415 PDI
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
antihypertensive drugscalcium channel blockersdrug repositioningmelanoma therapyrenin–angiotensin systemscoping reviewβ-blockers
Identifiers
PMID42645099
PMCPMC13511851
What OpenQuestion holds
Textmetadata
Read underepoch 390